Results 201 to 210 of about 22,026 (259)
The 'shark fin sign' - a morbid and rare electrocardiographic presentation in takotsubo cardiomyopathy. [PDF]
Eur Heart J Case RepHamideh M, Janjua A, Golzarian H.
europepmc +1 more source
Pneumopericardium, Pneumomediastinum, and Bilateral Pneumothoraxes Following Intubation and Repositioning in a 64-Year-Old Male Patient Undergoing Thoracic Decompression and Fusion. [PDF]
CureusMcIntyre MJ, Mathew K, Wakim GJ.
europepmc +1 more source
Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.
JAMA Intern MedRabin AS +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Journal of Pharmaceutics, 1996
Abstract Aerosols formed by three salts and the free base of albuterol were compared following their formation from similarly micronized crystalline powders held in a model dry powder inhaler (DPI) under varying environmental conditions. Aqueous solubility at 22°C was the greatest for albuterol adipate diethanolate (353 mg/ml), followed by albuterol ...
Rajkumari N. Jashnani, Peter R. Byron
exaly +2 more sources
Abstract Aerosols formed by three salts and the free base of albuterol were compared following their formation from similarly micronized crystalline powders held in a model dry powder inhaler (DPI) under varying environmental conditions. Aqueous solubility at 22°C was the greatest for albuterol adipate diethanolate (353 mg/ml), followed by albuterol ...
Rajkumari N. Jashnani, Peter R. Byron
exaly +2 more sources
JAAPA, 2022
ABSTRACT Albuterol has been a cornerstone of asthma treatment for several decades, but evidence suggests that it may be overused at the expense of more efficacious treatment. Albuterol may not even be appropriate for sole first-line rescue medication in some patients.
+5 more sources
ABSTRACT Albuterol has been a cornerstone of asthma treatment for several decades, but evidence suggests that it may be overused at the expense of more efficacious treatment. Albuterol may not even be appropriate for sole first-line rescue medication in some patients.
+5 more sources
Current Allergy and Asthma Reports, 2009
Albuterol has been used for more than 40 years to treat acute asthma exacerbations as a racemic mixture of isomers: the active form, (R)-albuterol, or levalbuterol, and (S)-albuterol, classically considered inert. The single-isomer formulation, levalbuterol, has been synthesized recently and used therapeutically when the racemate is deemed less ...
Bill T, Ameredes, William J, Calhoun
openaire +2 more sources
Albuterol has been used for more than 40 years to treat acute asthma exacerbations as a racemic mixture of isomers: the active form, (R)-albuterol, or levalbuterol, and (S)-albuterol, classically considered inert. The single-isomer formulation, levalbuterol, has been synthesized recently and used therapeutically when the racemate is deemed less ...
Bill T, Ameredes, William J, Calhoun
openaire +2 more sources
Multiple‐Dose Albuterol Kinetics
The Journal of Clinical Pharmacology, 1986Albuterol a beta‐adrenergic agonist bronchodilator, was studied in 12 healthy male volunteers to evaluate the steady‐state pharmacokinetics following oral administration of 4‐mg tablets, given every six hours for five days. The kinetics of albuterol were best described by a two‐compartment open model with first‐order absorption kinetics.
M L, Powell +6 more
openaire +2 more sources
Prednisolone Plus Albuterol Versus Albuterol Alone in Mild to Moderate Bronchiolitis
Clinical Pediatrics, 2000To evaluate combination therapy of mild to moderate bronchiolitis with bronchiodilators and corticosteroids, we treated 51 young children with first-time wheezing and symptoms of respiratory tract infection with albuterol plus either prednisolone or placebo for 5 days. Disease severity was scored on days 0, 2, 3, and 6. On day 2, prednisolone resulted
J, Goebel +5 more
openaire +2 more sources